Welcome to the July issue where, in our cover feature, we explore the sky-high potential of ADCs – will they live up to the hype? Upfront dives into the microbiome (the gut and the skin), plus regulatory developments in the Chinese advanced therapy sector. The challenges of drug repurposing are tackled in In My View, alongside the ever-evolving pharma job market. In Business, we lay out the steps to successfully commercializing orphan drugs, and find out how Merck has been preparing for a no-deal Brexit. In Profession, Claudia Zylberberg reveals her lessons learned. And finally, we Sit Down With serial entrepreneur and Medicine Maker Power Lister, Nigel Therobald.
July 26, 2019
While setbacks have held antibody drug conjugates (ADCs) from reaching their true potential, many in the industry remain confident in the ability of these products to boldly go where other therapeutics have failed to. But will these therapeutics live up to the ever-growing expectations surrounding them? Here, we explore the thoughts of industry experts on ADCs and share their predictions.
0 min read
July 25, 2019
With many APIs exhibiting a strong, bitter taste, taste-masking is essential, particularly for pediatric patients. Dr Krizia M Karry, Global Technical Marketing Manager for Pharma Solutions at BASF, discusses how taste-masking tactics have changed over the years and how to overcome some of the common challenges in the area.
0 min read
July 25, 2019
Biopharma manufacturers have been using the same assays for viral safety testing for decades, but new analytical technologies and molecular approaches offer a faster and more reliable approach. Until the next revolution…
0 min read
July 25, 2019
Biopharma manufacturers have been using the same assays for viral safety testing for decades, but new analytical technologies and molecular approaches offer a faster and more reliable approach. Until the next revolution…
0 min read
July 24, 2019
With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.
0 min read
July 24, 2019
Claudia uncovered a gap in the market for high quality ancillary materials during her time in the human plasma industry – and combined that with her belief in the future of cell and gene therapies to found Akron Biotech. Here, she reveals the lessons learned along the way and offers her perspective on the now booming advanced therapies industry.
0 min read
July 23, 2019
The uncertainty surrounding the UK’s future with Europe is having a measurable effect on the pharma industry (and many others). But I’m afraid to say the end is nowhere in sight.
0 min read
July 23, 2019
How does the gut microbiome influence the efficacy of Parkinson's medication?
0 min read
July 18, 2019
The FDA has accepted TraceLink's blockchain and digital recall project into its DSCSA Pilot Program
0 min read
July 18, 2019
Jobs for life are a thing of the past – make sure you develop the tools to survive and thrive, wherever your career takes you.
0 min read
July 17, 2019
Sitting Down With… Nigel Theobald, Chief Executive, N4 Pharma PLC, UK.
0 min read
July 16, 2019
Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?
0 min read
July 16, 2019
Early collaboration between couriers and manufacturers will be key to overcoming the logistical challenges presented by advanced therapies. Fortunately, history is on our side.
0 min read
July 9, 2019
Orphan drugs present a number of unique challenges for pharma companies looking to commercialize their products in the US. Collaborating to find patients for trials, improving diagnosis, demonstrating value, engaging with caregivers and developing specialized supply chains are just some of the things to consider.
0 min read
July 8, 2019
Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.
0 min read
July 4, 2019
Can artificial approaches trump the conventions of traditional organic synthesis for the production of raw pharmaceutical products within cells?
0 min read
July 4, 2019
The game “Tumor Quest” seeks to improve people’s understanding of cancer
0 min read
July 2, 2019
Harnessing the power of the microbiome, SkinBioTherapeutics is proving that skin-deep problems are resolvable
0 min read
June 18, 2019
Drug repurposing is in vogue, but it’s not always as easy as you think.
0 min read
June 4, 2019
Proposed legislation could offer patients in China the opportunity to purchase cell and gene therapies directly from hospitals, but it could also leave regulators out of the equation
0 min read
